178 related articles for article (PubMed ID: 15608321)
1. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP
Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
[No Abstract] [Full Text] [Related]
2. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
4. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
[No Abstract] [Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
8. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Mofidi M; Moghadam A
Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
[No Abstract] [Full Text] [Related]
10. Thyroid gland disorders in primary Sjögren's syndrome.
Punzi L; Ostuni PA; Betterle C; De Sandre P; Botsios C; Gambari PF
Rev Rhum Engl Ed; 1996 Dec; 63(11):809-14. PubMed ID: 9010968
[TBL] [Abstract][Full Text] [Related]
11. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
12. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
Ljung L; Uddhammar A; Rantapää-Dahlqvist S
Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
[No Abstract] [Full Text] [Related]
14. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
[No Abstract] [Full Text] [Related]
15. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
[TBL] [Abstract][Full Text] [Related]
17. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
18. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome.
Tobón GJ; Correa PA; Anaya JM
Ann Rheum Dis; 2005 May; 64(5):791-2. PubMed ID: 15834066
[No Abstract] [Full Text] [Related]
20. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
